De novo Drug Design using Reinforcement Learning with Multiple GPT Agents

Xiuyuan Hu, Guoqing Liu, Yang Zhao, Hao Zhang
2/12/2026

No official code found. Best implementation: HXYfighter/MolRL-MGPT (40 stars, last commit 2024-03-27).

Abstract

De novo drug design is a pivotal issue in pharmacology and a new area of focus in AI for science research. A central challenge in this field is to generate molecules with specific properties while also producing a wide range of diverse candidates. Although advanced technologies such as transformer models and reinforcement learning have been applied in drug design, their potential has not been fully realized. Therefore, we propose MolRL-MGPT, a reinforcement learning algorithm with multiple GPT agents for drug molecular generation. To promote molecular diversity, we encourage the agents to collaborate in searching for desirable molecules in diverse directions. Our algorithm has shown promising results on the GuacaMol benchmark and exhibits efficacy in designing inhibitors against SARS-CoV-2 protein targets. The codes are available at: https://github.com/HXYfighter/MolRL-MGPT.

View on arXivView PDF

Code Implementations(1)

NeurIPS 2023 paper: De novo Drug Design using Reinforcement Learning with Multiple GPT Agents

407PythonOct 7, 20232 years ago

Similar Papers

Cite this paper

@article{hu2026novo,
  title  = {De novo Drug Design using Reinforcement Learning with Multiple GPT Agents},
  author = {Xiuyuan Hu and Guoqing Liu and Yang Zhao and Hao Zhang},
  year   = {2026},
  eprint = {2401.06155},
  archivePrefix = {arXiv},
  url    = {https://arxiv.org/abs/2401.06155},
  journal = {NEURIPS 2023 2023}
}

Add a badge to your README

Shows whether official code is linked for this paper.

Code of Paper badge
[![Code of Paper](https://codeofpaper.com/badge/2401.06155.svg)](https://codeofpaper.com/paper/2401.06155)

Discussion